rs12936716

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002472.3(MYH8):​c.2016C>T​(p.Phe672Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0568 in 1,613,586 control chromosomes in the GnomAD database, including 3,012 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.052 ( 237 hom., cov: 32)
Exomes 𝑓: 0.057 ( 2775 hom. )

Consequence

MYH8
NM_002472.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.183

Publications

8 publications found
Variant links:
Genes affected
MYH8 (HGNC:7578): (myosin heavy chain 8) Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is predominantly expressed in fetal skeletal muscle. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in trismus-pseudocamptodactyly syndrome. [provided by RefSeq, Sep 2009]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 17-10406929-G-A is Benign according to our data. Variant chr17-10406929-G-A is described in ClinVar as Benign. ClinVar VariationId is 129672.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.183 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH8NM_002472.3 linkc.2016C>T p.Phe672Phe synonymous_variant Exon 18 of 40 ENST00000403437.2 NP_002463.2 P13535
MYHASNR_125367.1 linkn.167+691G>A intron_variant Intron 2 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH8ENST00000403437.2 linkc.2016C>T p.Phe672Phe synonymous_variant Exon 18 of 40 5 NM_002472.3 ENSP00000384330.2 P13535

Frequencies

GnomAD3 genomes
AF:
0.0521
AC:
7919
AN:
152090
Hom.:
235
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0406
Gnomad AMI
AF:
0.0582
Gnomad AMR
AF:
0.0434
Gnomad ASJ
AF:
0.0784
Gnomad EAS
AF:
0.0283
Gnomad SAS
AF:
0.117
Gnomad FIN
AF:
0.0528
Gnomad MID
AF:
0.0701
Gnomad NFE
AF:
0.0562
Gnomad OTH
AF:
0.0654
GnomAD2 exomes
AF:
0.0564
AC:
14168
AN:
251414
AF XY:
0.0602
show subpopulations
Gnomad AFR exome
AF:
0.0393
Gnomad AMR exome
AF:
0.0352
Gnomad ASJ exome
AF:
0.0800
Gnomad EAS exome
AF:
0.0229
Gnomad FIN exome
AF:
0.0546
Gnomad NFE exome
AF:
0.0547
Gnomad OTH exome
AF:
0.0560
GnomAD4 exome
AF:
0.0573
AC:
83776
AN:
1461380
Hom.:
2775
Cov.:
32
AF XY:
0.0589
AC XY:
42841
AN XY:
727022
show subpopulations
African (AFR)
AF:
0.0418
AC:
1399
AN:
33474
American (AMR)
AF:
0.0363
AC:
1622
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0811
AC:
2118
AN:
26130
East Asian (EAS)
AF:
0.0288
AC:
1142
AN:
39694
South Asian (SAS)
AF:
0.108
AC:
9289
AN:
86228
European-Finnish (FIN)
AF:
0.0538
AC:
2873
AN:
53416
Middle Eastern (MID)
AF:
0.0560
AC:
323
AN:
5768
European-Non Finnish (NFE)
AF:
0.0553
AC:
61428
AN:
1111564
Other (OTH)
AF:
0.0593
AC:
3582
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
4060
8121
12181
16242
20302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2384
4768
7152
9536
11920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0521
AC:
7933
AN:
152206
Hom.:
237
Cov.:
32
AF XY:
0.0534
AC XY:
3972
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0408
AC:
1695
AN:
41542
American (AMR)
AF:
0.0434
AC:
663
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0784
AC:
272
AN:
3468
East Asian (EAS)
AF:
0.0283
AC:
147
AN:
5186
South Asian (SAS)
AF:
0.118
AC:
568
AN:
4810
European-Finnish (FIN)
AF:
0.0528
AC:
559
AN:
10596
Middle Eastern (MID)
AF:
0.0719
AC:
21
AN:
292
European-Non Finnish (NFE)
AF:
0.0562
AC:
3819
AN:
67998
Other (OTH)
AF:
0.0643
AC:
136
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
367
734
1100
1467
1834
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0559
Hom.:
298
Bravo
AF:
0.0492
Asia WGS
AF:
0.0710
AC:
245
AN:
3478
EpiCase
AF:
0.0574
EpiControl
AF:
0.0575

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hecht syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
0.79
DANN
Benign
0.81
PhyloP100
0.18
Mutation Taster
=70/30
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12936716; hg19: chr17-10310246; COSMIC: COSV67965791; API